Loader
 

Folium Biosciences Completes Construction of One of the World’s Largest Cannabinoid Extraction and Purification Facility in Pueblo West, Colo. Press Release

Folium Biosciences Completes Construction of One of the World’s Largest Cannabinoid Extraction and Purification Facility in Pueblo West, Colo. Press Release

FOR IMMEDIATE RELEASE

Folium Biosciences Completes Construction of One of the World’s Largest Cannabinoid Extraction and Purification Facility in Pueblo West, Colo.  

Colorado Springs, Colo. — August 12, 2020 (Under embargo until August 12, 2020, 8:00 AM PST) – Folium Biosciences has completed buildout and received a Certificate of Occupancy for the world’s largest cannabinoid extraction and purification facility, located in Pueblo West, Colo.

The new 110,000-square-foot Pueblo West facility will produce up to 24,000 kg/~53,000 pounds of 0.0% THC broad spectrum CBD oil each month. To satisfy accelerating demand from CBD product manufacturers worldwide, the plant has dedicated production lines to meet US, EU, Japan, South Korea CBD regulatory requirements, among other countries.

FDA registered and state-of-the-art, the new Folium facility is purpose-built for extraction, purification and formulation of cannabinoids and terpenes. The plant will utilize CO2 extraction technology exclusively to produce phytocannabinoid-rich  0.0% THC broad spectrum CBD oil, adhering to a continuous process from decarboxylation to extraction that allows for a revolutionary inline terpene capture system.

“This past year really has been a ‘survival of the fittest’ moment for the CBD industry. Pandemic-related economic uncertainty has forced many manufacturers to cut back operations or completely go out of business,” explains Folium Chief Executive Officer and Co-Founder Kashif Shan. “I’m proud to say that Folium has moved aggressively in the other direction — looking at 2020 instead as a year to invest and solidify our leadership position. Completing construction on this new world class manufacturing facility is a testament to the strength of our market position. We move into 2021 with unrivaled capacity, ready to satisfy demand for the highest quality CBD oil for businesses all over the world.”

Folium’s operations in North America, South America, Europe and Asia provide a global reach as the worldwide cannabinoid industry continues its rapid growth. This international footprint and local market expertise coupled with the extensive scalable manufacturing made possible by the Pueblo West facility will enable  Folium to cultivate new channels for its innovative, high-quality, science-backed products more successfully than its competitors.

“Though our vision is global, we know the foundation for our success is local, in the Colorado communities in which we live and work,” adds Shan. “This milestone would not have been possible without the incredibly hard work of the Folium buildout team, our construction partners and the City of Pueblo Building Inspection, Fire Department and other officials, who worked throughout the COVID-19 crisis to get this project done.”

Folium will host a virtual ribbon cutting ceremony and live video tour of the facility as soon as federal, state and local health regulations allow.

About Folium

Headquartered in Colorado Springs, Colo., Folium Biosciences is a vertically integrated B2B producer, manufacturer, and distributor of hemp-derived non-psychoactive cannabinoids. Built on the core tenants of quality, science, scale, and innovation, Folium Biosciences controls all aspects of the supply chain from genetics and extraction to bulk and finished products. Folium Biosciences’ team of scientists, chemists, engineers, and other committed professionals deliver the world’s highest quality hemp-derived non-psychoactive cannabinoids products through a proprietary process, resulting in a THC content of 0.0%. Folium Biosciences was the first hemp company to be issued a Certificate of Free Sale and a Manufactured Food Establishment License by the Colorado Department of Public Health and Environment and continues to lead the industry in regulatory compliance and governance.

###

MEDIA CONTACT: Susie Hays, CMO, Q2Mark